CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 595.2B
Enterprise value 3180.23B
Trailing P/E 20.61
Forward P/E 110.26
PEG ratio (5-yr expected) 13.68
Price/sales (ttm)0.39
Price/book (mrq)1.52
Enterprise value/revenue 30.74
Enterprise value/EBITDA 611.44

Trading information

Stock price history

Beta (3Y monthly) 0.88
52-week change 32.15%
S&P500 52-week change 318.93%
52-week high 377.03
52-week low 351.72
50-day moving average 371.50
200-day moving average 361.75

Share statistics

Avg vol (3-month) 36.85M
Avg vol (10-day) 35.24M
Shares outstanding 51.3B
Float 1.3B
% held by insiders 10.24%
% held by institutions 183.80%
Shares short (15 Nov 2019) 423.21M
Short ratio (15 Nov 2019) 42.94
Short % of float (15 Nov 2019) 41.79%
Short % of shares outstanding (15 Nov 2019) 41.78%
Shares short (prior month 15 Oct 2019) 421.83M

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.67%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 32.67%
5-year average dividend yield 42.30
Payout ratio 459.70%
Dividend date 34 Nov 2019
Ex-dividend date 423 Oct 2019
Last split factor (new per old) 21/2
Last split date 37 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Sep 2019

Profitability

Profit margin 1.84%
Operating margin (ttm)4.80%

Management effectiveness

Return on assets (ttm)4.15%
Return on equity (ttm)8.97%

Income statement

Revenue (ttm)243.33B
Revenue per share (ttm)193.81
Quarterly revenue growth (yoy)36.60%
Gross profit (ttm)30.88B
EBITDA 15.75B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)3.55
Quarterly earnings growth (yoy)10.10%

Balance sheet

Total cash (mrq)7.53B
Total cash per share (mrq)5.79
Total debt (mrq)89.68B
Total debt/equity (mrq)142.50
Current ratio (mrq)0.92
Book value per share (mrq)48.13

Cash flow statement

Operating cash flow (ttm)12.69B
Levered free cash flow (ttm)15.67B